Results 161 to 170 of about 2,265 (188)
Some of the next articles are maybe not open access.
Tezepelumab in the Treatment of Uncontrolled Severe Asthma
Annals of Pharmacotherapy, 2022Objective: To review the pharmacology, efficacy, and safety of subcutaneous tezepelumab in the treatment of severe uncontrolled asthma. Data Sources: The PubMed database and ClinicalTrials.gov were searched using the following terms: tezepelumab, Tezspire, AMG157, and MEDI9929.
Jacqueline Feist +2 more
openaire +2 more sources
A Pharmacovigilance Analysis of Post-Marketing Safety of Tezepelumab
The Journal of Allergy and Clinical Immunology: In PracticeTezepelumab has shown promising efficacy for adult patients with severe asthma since its approval. However, the post-marketing safety evaluation of tezepelumab is currently lacking.To investigate the post-marketing safety of tezepelumab based on the US Food and Drug Administration Adverse Event Reporting System database.Adverse events (AEs) reported ...
Huqun, Li, Chongshu, Wang, Cuilian, Guo
openaire +2 more sources
NAVIGATOR steers asthma patients to tezepelumab
Medicom Conference Report ATS 2022, 2022Njira Lugogo, Rachel Giles
openaire +1 more source
Allergic bronchopulmonary aspergillosis successfully treated with tezepelumab
The Journal of Allergy and Clinical Immunology: In Practice, 2023openaire +2 more sources
Is tezepelumab the ubiquitous biologic for severe asthma?
The Lancet Respiratory Medicine, 2023Richard, Beasley, Anne B, Chang
openaire +2 more sources